Brief: Samsung Pharmaceutical to raise 39.47 bln won via rights issue

Samsung Pharm

30/06/2016 07:52

June 30 (Reuters) - Samsung Pharmaceutical  001360.KS  Co 
Ltd: 
     
    * Says it will raise 39.47 billion won via rights issue of 
common shares 
    * Says employee stock ownership association's preferred 
right to purchase the new shares at an allocation rate of 20 pct 
on Aug. 22 
    * Shareholders of record on July 19 will have rights to 
purchase 0.23474341 rights share for each share held during Aug. 
22 to Aug. 23 
    * Listing date of Sept. 9 for the new shares 
     
    Source text in Chinese: http://me2.do/FyM8QDMW 
    Further company Coverage:  001360.KS  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +861062674724; 
Reuters Messaging: lima.jin.reuters.com@reuters.net))